SYN

Synthetic Biologics (SYN)

Synthetic Biologics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:SYN

<< Previous 15 16 17 18 19 20 21 22 23 24 25 26 Next >>

Date	Time	Source	Headline	Symbol	Company
10/19/2012	4:25PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:SYN	Synthetic Biologics Inc
10/17/2012	2:46PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
10/17/2012	7:53AM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
10/09/2012	7:00AM	PR Newswire (US)	Charles B. Shoemaker, Ph.D., Joins Synthetic Biologics' Scientific Advisory Board	AMEX:SYN	Synthetic Biologics Inc
10/09/2012	6:19AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
10/05/2012	3:48PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
09/18/2012	7:00AM	PR Newswire (US)	Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections	AMEX:SYN	Synthetic Biologics Inc
09/12/2012	12:33PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
09/11/2012	4:44PM	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	AMEX:SYN	Synthetic Biologics Inc
09/11/2012	12:34PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	AMEX:SYN	Synthetic Biologics Inc
09/11/2012	12:32PM	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	AMEX:SYN	Synthetic Biologics Inc
08/31/2012	4:13PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	AMEX:SYN	Synthetic Biologics Inc
08/29/2012	1:11PM	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	AMEX:SYN	Synthetic Biologics Inc
08/15/2012	11:46AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
08/15/2012	11:43AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
08/14/2012	5:23PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
08/14/2012	5:21PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:SYN	Synthetic Biologics Inc
08/14/2012	5:02PM	PR Newswire (US)	Synthetic Biologics Reports Second Quarter 2012 Financial Results	AMEX:SYN	Synthetic Biologics Inc
08/10/2012	11:55AM	Edgar (US Regulatory)	Post-effective amendment filed solely to add exhibits to a registration statement (POS EX)	AMEX:SYN	Synthetic Biologics Inc
08/09/2012	5:02PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
08/09/2012	12:35PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
08/08/2012	7:00AM	PR Newswire (US)	Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases	AMEX:SYN	Synthetic Biologics Inc
07/26/2012	12:52PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:SYN	Synthetic Biologics Inc
07/24/2012	6:00AM	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	AMEX:SYN	Synthetic Biologics Inc
07/18/2012	5:29PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
07/12/2012	5:24PM	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	AMEX:SYN	Synthetic Biologics Inc
06/18/2012	5:03PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc
05/30/2012	1:56PM	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	AMEX:SYN	Synthetic Biologics Inc
05/15/2012	5:17PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:SYN	Synthetic Biologics Inc
05/15/2012	4:30PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYN	Synthetic Biologics Inc